SCHEMBL5345122

SCHEMBL5345122

CC1(C)C=Cc2c(ccc3c(O)c(C4c5c(c6ccc7c(c6oc5=O)C=CC(C)(C)O7)OC4O)c(=O)oc23)O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 8/20 0.40
BCHE P06276 3/20 0.40
PTPN1 P18031 3/20 0.38
RARA P10276 1/20 0.36
ACHE P22303 2/20 0.36
PDE2A O00408 1/20 0.36
PDE5A O76074 1/20 0.36
PDE9A O76083 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE10A Q9Y233 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5338619 0.77 PKLR (0.47) KDM4EMEN1MAPTKMT2ASMN1; SMN2
SCHEMBL5345493 0.75 NQO1 (0.51) KDM4ESMN1; SMN2
SCHEMBL5337618 0.75 ESR2 (0.49) KDM4ESMN1; SMN2
SCHEMBL5338654 0.73 ESR2 (0.38) BCHEACHEKDM4E
SCHEMBL5341632 0.73 HIF1A (0.33) CA1CA2
SCHEMBL5340558 0.71 GABRA1 (0.34) MEN1MAPTKMT2A
SCHEMBL5337992 0.71 TTR (0.34)
SCHEMBL5343002 0.66 CSNK2A2 (0.38) KDM4EMAPTKMT2A
SCHEMBL5342546 0.66 NQO1 (0.49) PDE2AKDM4EMEN1MAPTKMT2A
SCHEMBL29572212 0.65 ESR1 (0.56) PDE4DBCHEPTPN1RARAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US claimed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action LTC4S, CYP11B2, CYP11B1 PDE4D 1615/4885BCHE 942/4885PTPN1 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.